Journal De Bruxelles

NYSE - LSE

BCC	-1.13%	77.89	$
JRI	-0.2%	12.375	$
AZN	-1.1%	162.73	$
CMSD	-0.09%	21.16	$
BP	-0.97%	41.935	$
BCE	0.34%	23.48	$
RYCEF	-0.24%	20.7	$
CMSC	0.05%	21.32	$
RIO	-0.73%	104.02	$
RBGPF	-0.62%	70.69	$
NGG	0.51%	79.84	$
GSK	-0.4%	50.07	$
BTI	-0.3%	56.11	$
RELX	0.3%	36.41	$
VOD	0.35%	15.935	$

Featured

Meta's teen safety deal runs into an unsolved problem: proving age

Meta's landmark settlement with nearly every US state promises curfews and time limits for teens on Instagram and Facebook -- but rests on age and parent checks nobody has figured out how to make work.

Fed chair Warsh flags high US inflation as 'concerning'

US Federal Reserve chair Kevin Warsh on Friday offered rare insight into his economic outlook, flagging that high inflation in the world's largest economy was "concerning" and saying that he saw current interest rates as not being "restrictive."

Last news

Credit Suisse chief quits over Covid rules breach

The chairman of Credit Suisse resigned Monday over Covid quarantine violations, leaving the bank's new risk committee chief holding the reins and tasked with trying to stabilise the scandal-hit institution.

European stocks rise tracking big corporate news, China growth

European stock markets climbed on Monday as China's unexpectedly muted growth slowdown and optimism over the impact of the Omicron coronavirus variant boosted investor confidence.

Canada health authority approves Pfizer's anti-Covid pill

Canada's health authority said Monday it has approved Pfizer's anti-Covid pill, Paxlovid, for adults at high risk of progressing to serious disease.

Covid-flu joint booster jab possible late 2023: Moderna

Moderna aims to roll out a combined Covid-flu-RSV booster vaccine in late 2023, the US pharmaceutical firm said Monday, hoping a joint jab would encourage people to get an annual shot.

Journal De Bruxelles - Economy (English)